Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection

medRxiv(2022)10.1101/2022.02.09.22270692Source: DataRank Database

SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (21)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Justin DaSilva ORCID,Eva Bednarski ORCID,Frauke Muecksch ORCID,Fabian Schmidt ORCID,Yiska Weisblum ORCID

Live enrichment

PubMed:19910364 OpenAlex:https://openalex.org/W4211183550

National Institutes of Health

Grant: 5UL1TR001866-07

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success

National Institutes of Health

Grant: 5U19AI111825-02

Modulation of Human Dendritic Cell Development by Adjuvants and Vaccines

National Institutes of Health

Grant: 2R01AI078788-12A1

Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS

greenLicense: cc-by-nc

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2022/02/11/2022.02.09.22270692.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.02.09.22270692

repositoryhttps://doi.org/10.1101/2022.02.09.22270692

Europe_PMChttps://europepmc.org/article/PPR/PPR452871

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesSARS-CoV-2 detection and testing0301 basic medicine03 medical and health sciences

Keywords

VaccinationNeutralizationVirologyAntibodyNeutralizing antibodyImmunityTiterImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PopulationBiologyImmune systemMedicineCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being